Chinese Japanese Germany Korea

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Structure
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- structure
CAS No.
2805078-75-3
Chemical Name:
1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-
Synonyms
Sitagliptin Impurity 59 (Sitagliptin Tablets EP Impurity FP-B);1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-
CBNumber:
CB712215314
Molecular Formula:
C16H13F6N5O2
Molecular Weight:
421.3
MDL Number:
MOL File:
2805078-75-3.mol
Last updated:2023-05-15 10:43:32
Request For Quotation

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Properties

Density 1.67±0.1 g/cm3(Predicted)
solubility DMSO (Slightly), Methanol (Slightly, Heated)
pka 12.02±0.40(Predicted)
form Solid
color White to Off-White
FDA UNII XZ4N6T7TDZ

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Chemical Properties,Uses,Production

Uses

Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes.

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Preparation Products And Raw materials

Raw materials

Preparation Products

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Suppliers

Global( 7)Suppliers
Supplier Tel Email Country ProdList Advantage
hubei PharmaStandard Co., Ltd. 027-19050701 13545374703 cbbspring@163.com China 327 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761 3003392093@qq.com China 8012 55
QUALITY CONTROL SOLUTIONS LTD. 13670046396 ORDERS@QCSRM.COM China 18820 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954 tianwen.zhan@cato-chem.com China 7722 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212 2885426135@qq.com China 6580 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233 3641133981@qq.com China 9382 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234 2208093734@qq.com China 6348 58
Supplier Advantage
hubei PharmaStandard Co., Ltd. 58
Hubei Yangxin Medical Technology Co., Ltd. 55
QUALITY CONTROL SOLUTIONS LTD. 58
Cato Research Chemicals Inc. 58
Nanjing Huanuo Biomedical Technology Co., Ltd 58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 58

2805078-75-3(1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-)Related Search:

Sitagliptin Impurity 1 (R)-3-AMino-4-(2,4,5-trifluoro-phenyl)-butyric acid hydrochloride Acetic acid, 2-chloro-, 2-(2-chloroacetyl)hydrazide Benzenebutanoic acid, β-[[(3R)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]amino]-2,4,5-trifluoro-, (βR)- tert-Butyl ((R)-4-Oxo-4-(((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)amino)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
BOC-(S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID BLDAVCZELRQXFP-OWOJBTEDSA-N Sitagliptin N-Boc IMpurity Sitagliptin Defuoro IMpurity 3 (R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one Sitagliptin DeaMino IMpurity 1

1of3

1,2,4-Triazolo[3,4-c][1,4,7]triazecine-8,12(5H,9H)-dione, 6,7,10,11-tetrahydro-3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]- Sitagliptin Impurity 59 (Sitagliptin Tablets EP Impurity FP-B) 2805078-75-3